Compare · CLBS vs TLMD
CLBS vs TLMD
Side-by-side comparison of Caladrius Biosciences Inc. (CLBS) and SOC Telemed Inc. (TLMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLBS and TLMD operate in Managed Health Care (Health Care), so they compete in similar markets.
- TLMD is the larger of the two at $61.2M, about 1.4x CLBS ($43.6M).
- TLMD has more recent analyst coverage (8 ratings vs 0 for CLBS).
- Company
- Caladrius Biosciences Inc.
- SOC Telemed Inc.
- Price
- $6.45+1176.72%
- $3.00+0.00%
- Market cap
- $43.6M
- $61.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Managed Health Care
- Managed Health Care
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 8
Caladrius Biosciences Inc.
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced therapy for treating no-option refractory disabling angina; CLBS16 that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
SOC Telemed Inc.
SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, and teleICU. The company was founded in 2004 and is based in Reston, Virginia.
Latest CLBS
- SEC Form 4: Mazzo David J covered exercise/tax liability with 397 shares, decreasing direct ownership by 0.41% to 96,543 units
- SEC Form 4: Mazzo David J covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 1% to 96,940 units
- SEC Form 4: Ruoslahti Erkki was granted 20,000 shares
- SEC Form 4: Klosk Steven M was granted 20,000 shares, increasing direct ownership by 198% to 30,090 units
- SEC Form 4: Henson Heidi was granted 20,000 shares
- SEC Form 4: Flowers Cynthia Louise was granted 20,000 shares, increasing direct ownership by 206% to 29,721 units
- SEC Form 4: Brown Gregory B was granted 20,000 shares, increasing direct ownership by 201% to 29,934 units
- SEC Form 4: Azab Mohammad was granted 20,000 shares, increasing direct ownership by 104% to 39,200 units
- SEC Form 4: Slack David W. was granted 24,000 shares and covered exercise/tax liability with 3,358 shares
- SEC Form 4: Mazzo David J was granted 60,000 shares and covered exercise/tax liability with 11,315 shares, increasing direct ownership by 99% to 97,970 units
Latest TLMD
- Securonix Appoints Eunice Kim as General Counsel
- SEC Form 15-12B filed by SOC Telemed Inc.
- SEC Form EFFECT filed by SOC Telemed Inc.
- SEC Form EFFECT filed by SOC Telemed Inc.
- SEC Form SC 13D/A filed by SOC Telemed Inc. (Amendment)
- SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)
- SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)
- SEC Form 4: Shulman Steven J returned $3,336,873 worth of shares to the company (1,112,291 units at $3.00), closing all direct ownership in the company (tax liability)
- SEC Form 4: Mikula David returned $1,489,728 worth of shares to the company (496,576 units at $3.00), closing all direct ownership in the company (for withholding tax)
- SEC Form 4: Mcgeorge Anne returned $175,161 worth of shares to the company (58,387 units at $3.00), closing all direct ownership in the company (for tax liability)